Arcutis Biotherapeutics (ARQT) Operating Expenses (2019 - 2026)
Arcutis Biotherapeutics (ARQT) posted quarterly Operating Expenses of $114.5 million for Q1 2026, up 26.68% year-over-year from $90.4 million in Q1 2025, and up 3.03% quarter-over-quarter from $111.1 million in Q4 2025.
Arcutis Biotherapeutics (ARQT) Operating Expenses (2019 - 2026) Analysis & Trends
Arcutis Biotherapeutics' Operating Expenses history runs 8 years deep, the most recent figure standing at $114.5 million for Q1 2026.
- In Q1 2026, Operating Expenses rose 26.68% year-over-year to $114.5 million; the TTM figure through Mar 2026 stood at $412.4 million (up 23.43% YoY), while the FY2025 annual figure was $388.3 million, up 19.5% from the prior year.
- Operating Expenses for Q1 2026 stood at $114.5 million, up from $111.1 million in the prior quarter.
- The five-year high for Operating Expenses was $114.5 million in Q1 2026, with the low at $62.6 million in Q1 2022.
- The 5-year median for Operating Expenses is $80.9 million (2024), against an average of $84.3 million.
- The sharpest annual moves came in 2022 and 2023: Operating Expenses jumped 84.79% in 2022, then slipped 28.88% in 2023.
- Arcutis Biotherapeutics' Operating Expenses stood at $71.4 million in 2022, then rose by 4.64% to $74.7 million in 2023, then gained by 5.75% to $79.0 million in 2024, then jumped by 40.67% to $111.1 million in 2025, then grew by 3.03% to $114.5 million in 2026.
- Business Quant data shows ARQT's Operating Expenses at $114.5 million in Q1 2026, $111.1 million in Q4 2025, and $90.7 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 2.09 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 3.00 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 2.89 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 505.13 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 1.21 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 4,978.15 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 541.02 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 1.06 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 427.03 Mn |
| 10 | Arcutis Biotherapeutics | 3.29 Bn | 3.05 Bn | 118.92 Mn | 113.43 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 113.43 Mn |
| Mar 31, 2026 | 114.49 Mn |
| Dec 31, 2025 | 111.12 Mn |
| Sep 30, 2025 | 90.69 Mn |
| Jun 30, 2025 | 96.12 Mn |
| Mar 31, 2025 | 90.38 Mn |
| Dec 31, 2024 | 78.99 Mn |
| Sep 30, 2024 | 83.82 Mn |
| Jun 30, 2024 | 80.94 Mn |
| Mar 31, 2024 | 81.19 Mn |
| Dec 31, 2023 | 74.70 Mn |
| Sep 30, 2023 | 75.01 Mn |
| Jun 30, 2023 | 71.95 Mn |
| Mar 31, 2023 | 79.05 Mn |
| Dec 31, 2022 | 71.39 Mn |
| Sep 30, 2022 | 105.47 Mn |
| Jun 30, 2022 | 65.83 Mn |
| Mar 31, 2022 | 62.63 Mn |
| Dec 31, 2021 | 71.29 Mn |
| Sep 30, 2021 | 57.08 Mn |